...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

RVXOT, seeing that (OTCMKTS: RVXCF) trades on the OTC market and posted on the RVX page to the right-hand column, of the Resverlogix hub, why can't Agoracom similarly post the SPP for ZHCLF (Zenith)?

I'd rather not see that.  I cringe every time I see ZHCLF discussed.  I have to wonder what the increased focus on ZHCLF does for the price of future private placements.  I realize ya can't get big quantities on ZHCLF without moving the price, but still........

 

Share
New Message
Please login to post a reply